Troubled by Ads? Install Dainik Bhaskar app for news without ads
New Delhi8 hours ago
- Copy link
The Delhi High Court on Tuesday heard a petition filed by the central government regarding corona and drug management. The High Court directed the Central Government to formulate a policy on the distribution of liposomal amphotericin-B drug for the treatment of Mucor mycosis (black fungus) and to prioritize patients so as to save some lives.
Regarding the acute shortage of amphotericin-B medicine effective in treating black fungus, the court told the central government that, we have to focus on protecting more youth than the elderly who are suffering from this disease.
A bench of Justice Vipin Sanghi and Justice Jasmeet Singh said that, if two people in the same family are sick, one is 80 years old and the other is 35 years old. If there is only one dose of medicine, then who will we try to save? It is very difficult to determine this. The court said that if we want to choose someone in this situation, then we have to give priority to the youth.
However, this is a very cruel decision. But the future of this country rests on the youth. Therefore it is necessary to save them first.
The bench has ordered the Indian Council of Medical Research (ICMR) to bring clear guidelines on the use of liposomal amphotericin-B, plain amphotericin-B and posaconazole to be used in the treatment of black fungus.
80 year old man has lived his life
The court said that the 80-year old has lived his life. They are not going to take this country forward. So we have to choose the youth. We are not saying that someone’s life is more important and someone’s less. Every single life is important. But we have to decide.
The court said that we have to see who is more likely to survive, the medicines will have to be distributed accordingly. However, it is very difficult to decide who should be saved or who should be left to die in the midst of shortage of medicine.